1st Quarter - Amendment
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Income
—
Expenses
$67,350
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | May 18, 2012 | $23,000 | Replaced |
| 1st Quarter - Amendment | Oct 18, 2012 | $67,350 | Replaced |
| 1st Quarter - Amendment (this page) | Aug 6, 2013 | $67,350 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The Prescription Drug User Fee Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GEORGE DAHLMAN | — |
Budget/Appropriations BUD
Funding for blood cancer education program and blood cancer research through the Labor, Health and Human Services, and Education appropriations bill, and the DoD appropriations bill for FY 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| GEORGE DAHLMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.